Cargando…
Successful Lifetime/Long-Term Medical Treatment of Acid Hypersecretion in Zollinger-Ellison Syndrome (ZES): Myth or Fact? Insights from an Analysis of Results of NIH Long-Term Prospective Studies of ZES
SIMPLE SUMMARY: Zollinger-Ellison syndrome (ZES) has, since its original description, been characterized by extreme acid hypersecretion due to a neuroendocrine tumor ectopically secreting gastrin, resulting in severe, recalcitrant peptic ulcer disease/gastroesophageal reflux disease (GERD) that is r...
Autores principales: | Ito, Tetsuhide, Ramos-Alvarez, Irene, Jensen, Robert T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000208/ https://www.ncbi.nlm.nih.gov/pubmed/36900170 http://dx.doi.org/10.3390/cancers15051377 |
Ejemplares similares
-
Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger–Ellison Syndrome
por: Lee, Lingaku, et al.
Publicado: (2019) -
Long-term (2–5 years) adverse clinical outcomes associated with ZES versus SES, PES and EES: A Meta-Analysis
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2017) -
Síndrome de Zollinger-Ellison : (Revisión Bibliográfica) /
por: Barradas Vela, José Luis
Publicado: (1994) -
ProZES: the methodology and software tool for assessment of assigned share of radiation in probability of cancer occurrence
por: Ulanowski, Alexander, et al.
Publicado: (2020) -
An Unusual Presentation of Zollinger-Ellison Syndrome
por: Sinagra, Emanuele, et al.
Publicado: (2013)